TY  - GEN
AU  - Arjona-Sanchez, A
AU  - Barrios, Pedro
AU  - Boldo-Roda, E
AU  - Camps, B
AU  - Carrasco-Campos, J
AU  - Concepcion-Martin, V
AU  - Garcia-Fadrique, A
AU  - Gutierrez-Calvo, A
AU  - Morales, Rafael
AU  - Ortega-Perez, G
AU  - Perez-Viejo, E
AU  - Prada-Villaverde, A
AU  - Torres-Melero, J
AU  - Vicente, E
AU  - Villarejo-Campos, P
AU  - Sanchez-Hidalgo, JM
AU  - Casado-Adam, A
AU  - Garcia-Martin, Ruben
AU  - Medina, Manuel
AU  - Caro, T
AU  - Villar, C
AU  - Aranda, Enrique
AU  - Cano-Osuna, MT
AU  - Diaz-Lopez, C
AU  - Torres-Tordera, E
AU  - Briceno-Delgado, FJ
AU  - Rufian-Pena, S
PY  - 2018
DO  - 10.1186/s12885-018-4096-0
SN  - 1471-2407
UR  - https://hdl.handle.net/20.500.12105/22532
AB  - Background: Local relapse and peritoneal carcinomatosis (PC) for pT4 colon cancer is estimated in 15,6% and 36,7% for 12 months and 36 months from surgical resection respectively, achieving a 5 years overall survival of 6%. There are promising results...
LA  - eng
PB  - BioMed Central (BMC)
KW  - Colon carcinoma
KW  - HIPEC
KW  - Peritoneal carcinomatosis
KW  - Chemoprophylaxis
KW  - Aged
KW  - Kaplan-Meier Estimate
KW  - Young Adult
KW  - Adult
KW  - Hyperthermia, Induced
KW  - Humans
KW  - Combined Modality Therapy
KW  - Middle Aged
KW  - Male
KW  - Female
KW  - Colorectal Neoplasms
KW  - Treatment Outcome
KW  - Antibiotics, Antineoplastic
KW  - Mitomycin
TI  - HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma
TY  - research article
ER  -